Novel Compounds as MALT1 Inhibitors for Treating Cancer

Provided herein are novel compounds as MALT1 inhibitors, pharmaceutical compositions, use of such compounds in treating cancer, and processes for preparing such compounds.

Authors

Publication Details

Journal
ACS Medicinal Chemistry Letters
Published
2026-02-04
DOI
https://doi.org/10.1021/acsmedchemlett.6c00037
Citations
1
Primary Topic
NF-κB Signaling Pathways
Type
article
Field-Weighted Citation Impact
24.82
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Novel Compounds as MALT1 Inhibitors for Treating Cancer

Ram W. Sabnis
1 citations
ACS Medicinal Chemistry Letters
NF-κB Signaling Pathways
24.82
article

Novel Compounds as MALT1 Inhibitors for Treating Cancer

Ram W. Sabnis
article en
1 citations

Abstract

Provided herein are novel compounds as MALT1 inhibitors, pharmaceutical compositions, use of such compounds in treating cancer, and processes for preparing such compounds.

ACS Medicinal Chemistry LettersVol. 17(2)
Openalex Percentile: Top 1%
NF-κB Signaling Pathways
24.82
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Novel Compounds as MALT1 Inhibitors for Treating Cancer — Ram W. Sabnis · ACS Medicinal Chemistry Letters (2026) | TGRS Research Map | TGRS